AIDS Vaccine Disappoints
A promising AIDS vaccine developed by Merck has proven unsuccessful in a major international trial. It's a huge setback, not just because this particular vaccine was further along than others, but because it used a new strategy shared by a number of alternatives.A promising AIDS vaccine developed by Merck has proven unsuccessful in a major international trial. It’s a huge setback, not just because this particular vaccine was further along than others, but because it used a new strategy shared by a number of alternatives.
TRUTHDIG’S JOURNALISM REMAINS CLEARAP:
It was a high-profile failure in the daunting quest to develop a vaccine to prevent AIDS. Merck’s vaccine was the farthest along and was closely watched by experts in the field.
Officials at the company, based in Whitehouse Station, N.J., said 24 of 741 volunteers who got the vaccine in one segment of the experiment later became infected with HIV, the virus that causes AIDS. In a comparison group of volunteers who got dummy shots, 21 of 762 participants also became infected.
“It’s very disappointing news,” said Keith Gottesdiener, head of Merck’s clinical infectious disease and vaccine research group. “A major effort to develop a vaccine for HIV really did not deliver on the promise.”
The storytellers of chaos tried to manipulate the political and media narrative in 2025, but independent journalism exposed what they tried to hide.
When you read Truthdig, you see through the illusion.
Support Independent Journalism.
TD Original
Gilead’s price drop for the HIV prevention drug lenacapavir is a smoke screen for monopoly medicine.
Health & Wellness
Community leaders in Mississippi and beyond race to limit the damage of governmental cuts to HIV care funding.
Film
A documentary tells the story of Carl Bean, a disco star who preached the gospel of love and acceptance at the height of the AIDS crisis.
Health & Wellness
A disruption in federal funds has jeopardized HIV testing and outreach in Mississippi, and researchers warn of a resurgence of the epidemic in the South.
Health & Wellness
Aging with HIV comes with an increased risk of health complications later in life. Is the U.S. health care system prepared to treat this growing population?
Opinion
A HIV survivor and former instructor reflects on his experiences.
You need to be a supporter to comment.
There are currently no responses to this article.
Be the first to respond.